title: Platelet-activating factor in human luteal phase endometrium.
abstract: Platelet-activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphorylcholine) is one of the most potent mediators of vascular permeability. PAF levels change in the rabbit endometrium just prior to implantation, which suggests that PAF may be a key substance transducing preimplantation embryonic signals. To study whether PAF was present in the human endometrium, and if so, to determine the cellular origin and hormonal regulation of endometrial PAF, specimens were obtained from 14 women (aged 23-42 yr) undergoing elective hysterectomy during the luteal phase of the cycle (plasma progesterone levels greater than 2 ng/ml). No specimens were taken from women with malignant uterine pathology. Stromal cells and epithelial glandular cells were separated by collagenase and DNAse digestion, and then cultured to confluence in vitro in medium 199. Radioimmunoassays of prostaglandin F (PGF) and prolactin in the culture media were used to confirm cell type and viability. PGF release into the culture medium from stromal cells was low (control 1.52 +/- 0.20 ng/ml), and unchanged by hormone treatment. In contrast, release of PGF from unstimulated glandular cells was 6.05 +/- 0.52 ng/ml, and was significantly increased (p less than 0.05) by estradiol or progesterone plus estradiol, to 12.17 +/- 1.67, and 8.60 +/- 0.81, respectively. Progesterone alone was without effect. Prolactin was secreted by stromal cell cultures, increasing steadily from 24 to 120 h. The levels in the medium were increased by progesterone. PAF activity was assessed by rabbit platelet aggregation and serotonin-release bioassays after lipid extraction and separation by thin-layer chromatography.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Obstetrics and Gynecology, University of Texas Health Science Center, San Antonio 78284.
authors.forename: A A
authors.initials: AA
authors.lastname: Alecozay
authors.forename: B G
authors.initials: BG
authors.lastname: Casslén
authors.forename: R M
authors.initials: RM
authors.lastname: Riehl
authors.forename: F D
authors.initials: FD
authors.lastname: Deleon
authors.forename: M J
authors.initials: MJ
authors.lastname: Harper
authors.forename: M
authors.initials: M
authors.lastname: Silva
authors.forename: T A
authors.initials: TA
authors.lastname: Nouchi
authors.forename: D J
authors.initials: DJ
authors.lastname: Hanahan
mesh_terms: D000328:Adult; D001681:Biological Assay; D002478:Cells, Cultured; D002855:Chromatography, Thin Layer; D046508:Culture Techniques; D004717:Endometrium / Q000378:metabolism*; D005260:Female; D006801:Humans; D008183:Luteal Phase / Q000502:physiology*; D010972:Platelet Activating Factor / Q000096:biosynthesis* / Q000302:isolation & purification / Q000378:metabolism; D011863:Radioimmunoassay
chemical_list: D010972:Platelet Activating Factor